TY - JOUR T1 - Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4-5 chronic kidney disease: a systematic review and meta-analysis JF - Virol J Y1 - 2019 A1 - Li, M A1 - Chen, J A1 - Fang, Z A1 - Li, Y A1 - Lin, Q VL - 16 SP - 34 IS - 1 ER -